A stock picker's guide to Ansell Limited in 2014

Ansell is a stock that deserves a place on investors' watchlists.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Financial year (FY) 2013 was a respectable year for Ansell Limited (ASX: ANN) with sales, earnings and dividends all increasing. This result was despite the firm facing a number of headwinds throughout the year. These headwinds included:

  • Negative foreign exchange impact
  • Increase in manufacturing costs (labour, utilities, water)
  • Increase in competitive pressures
  • Decline in government spending on healthcare and defence

Despite these headwinds, Ansell's management has positioned the firm for continued growth in sales and profits – which occurred in FY 2013 but which have also positioned the company for further growth in FY 2014.

These initiatives have included:

  • Merger and acquisitions
  • New product development (NPD) launches
  • Improved manufacturing productivity and capability
  • Continued expansion into emerging markets

On the point of NPD, Ansell impressively increased its new products to market in FY 2013 at seven times the rate of FY 2010. While on the point of emerging market (EM) expansion, Ansell grew sales in these regions by 17% with EM now representing 27% of total sales in the group.

Ansell provided guidance at its AGM for growth in earnings per share between 5% and 11% for FY 2014 and stated that economic conditions remained mixed but that it was achieving moderate organic sales growth. Since the AGM, the company has completed the US$615 million acquisition of BarrierSafe Solutions. Pleasingly for shareholders, management has stated that it expects the BarrierSafe acquisition, on a normalised basis (excluding one-off transaction costs from the acquisition) to be earnings-per-share accretive in FY 2014.

Foolish takeaway

Ansell is one of a relatively small group of large, listed ASX companies that offer investors a similar mix of global growth potential and significant defensive earnings capability. It's interesting to note that other members of this "group" also hail from the healthcare sector. CSL Limited (ASX: CSL) and Sonic Healthcare Limited (ASX: BXB) being two examples.

With a market capitalisation of $2.5 billion and the ability to acquire firms such as BarrierSafe, despite its market-leading status in a number of markets, Ansell still has the ability to expand and grow. 2014 appears to be shaping up to be another good year for this impressive company.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »